The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports
EEG and Cognitive Biomarkers Based Mild Cognitive Impairment Diagnosis - ScienceDirect
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter
Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience
C-reactive protein and risk of cognitive decline: The REGARDS study | PLOS ONE
Initial Evaluation of the Patient with Suspected Dementia | AAFP
Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
Laboratory Diagnosis of Creutzfeldt–Jakob Disease | NEJM